SC 13G: INOVIO PHARMACEUTICALS, INC.

Ticker: INO · Form: SC 13G · Filed: Apr 26, 2024 · CIK: 1055726

Inovio Pharmaceuticals, INC. SC 13G Filing Summary
FieldDetail
CompanyInovio Pharmaceuticals, INC. (INO)
Form TypeSC 13G
Filed DateApr 26, 2024
Risk Levellow
Pages6
Reading Time7 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by INOVIO PHARMACEUTICALS, INC..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G filing submitted by Inovio Pharmaceuticals, INC. (ticker: INO) to the SEC on Apr 26, 2024.

What is the risk level of this SC 13G filing?

This filing has been assessed as low risk.

What are the key financial figures in this filing?

Key dollar amounts include: $0.001 (INC. (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securiti).

How long is this filing?

Inovio Pharmaceuticals, INC.'s SC 13G filing is 6 pages with approximately 1,664 words. Estimated reading time is 7 minutes.

Where can I view the full SC 13G filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 1,664 words · 7 min read · ~6 pages · Grade level 10.8 · Accepted 2024-04-26 16:01:17

Key Financial Figures

Filing Documents

(a)Name of Issuer

Item 1. (a)Name of Issuer INOVIO PHARMACEUTICALS, INC.

(b)Address of Issuer’s Principal

Item 1. (b)Address of Issuer’s Principal Executive Offices 660 W. Germantown Pike, Suite 110 Plymouth Meeting, Pennsylvania 19462

(a)Names of Persons Filing

Item 2. (a)Names of Persons Filing: (i) Deep Track Capital, LP (ii) Deep Track Biotechnology Master Fund, Ltd. (iii) David Kroin

( b)Address

Item 2. ( b)Address of Principal Business Office: (i) 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830 (ii) c/o Walkers Corporate Limited, 190 Elgin Ave, George Town, KY1-9001, Cayman Islands (iii) c/o Deep Track Capital, LP, 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830

(c) Citizenship

Item 2. (c) Citizenship: (i) Delaware (ii) Cayman Islands (iii) United States

(d)Title of Class of Securities

Item 2. (d)Title of Class of Securities Common Stock, $0.001 Par Value (the “Common Stock”)

(e) CUSIP No

Item 2. (e) CUSIP No.: 45773H409 CUSIP No. 45773H409 SCHEDULE 13G Page 6 of 9 Pages

If

Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not Applicable CUSIP No. 45773H409 SCHEDULE 13G Page 7 of 9 Pages Item 4.Ownership Information with respect to the Reporting Persons' ownership of the Common Stock as of April 26, 2024, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person. The amount beneficially owned by each Reporting Person is determined based on 25,964,187 Common Stock. Item 5.Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial Item 6.Ownership of More Than Five Percen

View Full Filing

View this SC 13G filing on SEC EDGAR

View on Read The Filing